Procter & Gamble Company (PG) Q1 2027: Revenue Growth Steady, EPS Up Slightly — Cautiously Optimistic: Gaps +3.4% at Open — Post-Earnings Analysis

Procter & Gamble Company (NYSE: PG) reported its first quarter results for fiscal year 2027, revealing a net sales increase of $0.9 billion or +4.0% year-over-year, reaching $23.3 billion. This growth was mirrored in organic sales, which also rose by +4.0%. Diluted earnings per share (EPS) increased by $0.02 to $1.97, reflecting a +1% growth compared to the previous year. Core EPS also saw a similar increase, rising to $2.00, up +1% from the prior year.

This quarter's performance can be viewed as a positive outcome for shareholders, as the company managed to maintain revenue growth amidst rising operating costs. The slight increase in EPS indicates that P&G is effectively managing its profitability despite external pressures.

Key Metrics:

• Net Sales: $23.3 billion, up $0.9 billion or +4.0% YoY
• Organic Sales: +4.0% YoY
• Diluted EPS: $1.97, up +1% YoY
• Core EPS: $2.00, up +1% YoY
• Operating Cash Flow: $5.8 billion
• Free Cash Flow: $4.4 billion
• Free Cash Flow Productivity: 93%
• Cash Returned to Shareholders: $3.9 billion (including $2.6 billion in dividends and $1.3 billion in share repurchases)

P&G's ability to achieve a 4.0% increase in both net and organic sales is commendable, especially in a challenging economic environment characterized by rising commodity costs and inflationary pressures. The company reported a gross margin decrease of 160 basis points, primarily due to higher commodity costs and product reinvestments, which were partially offset by productivity savings.

Shareholder Returns and Guidance:

P&G returned $3.9 billion to shareholders through dividends and share repurchases, demonstrating its commitment to returning capital while navigating cost pressures. The company maintained its fiscal year 2027 guidance for organic sales growth in the range of +1% to +3% and diluted EPS growth of +1% to +5%. This guidance reflects the anticipated impact of the Thorne acquisition and ongoing cost challenges.

Forward-Looking Catalysts:

Investors should keep an eye on P&G's ability to manage its cost structure and maintain sales momentum in the upcoming quarters. The company faces headwinds from commodity costs, which are expected to impact EPS growth by approximately $0.79 per share, translating to an 11% drag on core EPS growth for fiscal 2027. Additionally, P&G's focus on innovation and premium product offerings will be crucial in driving future sales growth.

In summary, while the quarter showed modest growth, the challenges ahead require careful monitoring. P&G's strategic initiatives and commitment to shareholder returns position it well for the future, but investors should remain vigilant regarding external economic pressures.

Amounts in millions except per share amounts

Amounts in millions

Quarterly Earnings — Revenue vs. Estimate

Revenue vs. Estimate — 5 Quarters

EPS vs. Estimate — 5 Quarters

Analyst Ratings & Price Targets

Wall Street analysts have shown mixed sentiment toward The Procter & Gamble Company (PG) in recent months, with notable rating changes reflecting diverging views. Evercore ISI upgraded PG from In-line to Outperform on October 6, 2026, setting a $166 price target, while Argus downgraded it from Buy to Hold in August. Bernstein initiated coverage at Market Perform with a $156 target in June, and TD Cowen downgraded PG to Hold in January with the same target. Erste Group’s February upgrade to Buy was reversed by a March downgrade to Hold. The consensus price target stands near $159, suggesting modest upside from PG’s current trading levels, though the spread between bullish ($166) and neutral ($156) targets indicates cautious optimism. The balance of upgrades and downgrades reflects uncertainty around near-term earnings momentum amid macroeconomic pressures.

Technical Analysis — 90-Day Price Chart

Procter & Gamble (PG) trades at $166.59, near its 52-week high of $166.79, signaling strong bullish momentum with limited overhead resistance. The stock remains well above its key moving averages—SMA20 ($152.07), SMA50 ($148.05), and SMA200 (implied)—confirming a sustained uptrend without recent bearish crossovers. The RSI(14) at 84.5 indicates severely overbought conditions, suggesting potential near-term consolidation or pullback risk. Volume at 10.7M shares exceeds the 20-day average of 9.3M, reinforcing conviction in the uptrend. Given its proximity to the 52-week high, immediate resistance is minimal, while the SMA50 near $148 may serve as primary support on any retracement. The current technical posture remains bullish but stretched, warranting caution given elevated RSI levels.